Terry Poling
Family Medicine · Wichita, KSNPI 1144282716
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,627 of the $9,111 with a category attached, or 61.8%. 27 manufacturers reported payments, led by CSL Behring at 30.4% of the total. Reporting peaked in 2019 at $5,082 and has fallen 70.3% since, to $1,508 in 2023. Among family medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $55.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$3K
- Boehringer Ingelheim International GmbH$2K
- Hexal AG$1K
- Merck$1K
- Pfizer$751
- Amgen$388
- plus $1K from 21 others
Across 3,193 payments — averaging $7612.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$9.5M
- AstraZeneca$6M
- Pfizer$2.8M
- GSK$1.9M
- Valneva Austria GmbH$967K
- Johnson & Johnson$872K
- plus $2.1M from 12 others
What the payments were for
- Travel & lodging$5,62762%
- Food & beverage$3,48438%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 18 | $2,770 |
| Boehringer Ingelheim International GmbH | 11 | $1,508 |
| Hexal AG | 2 | $1,484 |
| Merck | 9 | $1,008 |
| Pfizer | 4 | $751 |
| Amgen | 30 | $388 |
| Novo Nordisk | 25 | $292 |
| Lilly USA, LLC | 14 | $170 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Amarin Pharma, Inc. | 7 | $92 |
| Eisai Inc. | 6 | $78 |
| AbbVie | 5 | $73 |
| Bayer | 3 | $58 |
| Sanofi-aventis U.S. LLC | 4 | $47 |
| Xeris Pharmaceuticals, Inc. | 3 | $46 |
| Abbott | 2 | $31 |
| Ironwood Pharmaceuticals, Inc | 2 | $30 |
| Esperion Therapeutics, Inc. | 2 | $27 |
| Boehringer Ingelheim | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Johnson & Johnson | 2 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Apria Healthcare LLC | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| Novartis | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Privigen$2,193
- GARDASIL 9$766
How this compares
$9,111 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Joseph SackWichita$21K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.